Latest Microarrays Stories
Service offers highest quality data from banked samples with lowest sample input. Santa Clara, CA (Vocus/PRWEB) April 04, 2011 Affymetrix, Inc. (NASDAQ: AFFX) today announced at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 in Orlando, Florida, the launch of its second-generation OncoScanâ„¢ FFPE Express platform (formerly MIP Copy Number Service). OncoScanâ„¢ FFPE Express 2.0 offers enhanced coverage of tumor suppressors and oncogenes and provides...
HAMBURG, Germany, April 4, 2011 /PRNewswire/ -- Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to Labnet International for their Labnet(R) Multigene(TM) gradient Thermal Cyclers, including US patent Nos. 6,767,512 and 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler(R) pro gradient, Mastercycler gradient and Mastercycler ep realplex models. Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes...
WOBURN, Mass., March 22, 2011 /PRNewswire/ -- Avantra Biosciences has announced they are selling their new and improved proprietary PATH® Protein Microarray Ultra-thin Nitrocellulose Slides. Additionally, Avantra is discussing the possibility of partnering with certain parties to expand the distribution network for the PATH slides. The PATH Slide is the first protein microarray slide to provide the many benefits of nitrocellulose in a thin film that allows very low background...
FREMONT, Calif. and SAN CARLOS, Calif., March 21, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, and NuGEN Technologies, Inc., a leader in innovative genomic samples preparation, today announced they will co-develop and co-market simple, seamlessly integrated workflows for gene expression profiling and target enrichment to enable researchers to more easily achieve high-throughput, high-density...
A major milestone in microfluidics could soon lead to stand-alone, self-powered chips that can diagnose diseases within minutes. The device, developed by an international team of researchers from the University of California, Berkeley, Dublin City University in Ireland and Universidad de ValparaÃso Chile, is able to process whole blood samples without the use of external tubing and extra components.The researchers have dubbed the device SIMBAS, which stands for Self-powered Integrated...
BELMONT, Calif., March 16, 2011 /PRNewswire/ -- Phalanx Biotech Group, a global provider of genomic analysis services, announces its newest expression microarray - the Rat Whole Genome OneArray®. Curated from RefSeq.42 and Ensemble.59 databases, the Rat OneArray® is comprised of 25,338 long-oligonucleotide probes engineered to meet specific isothermal requirements for superb hybridization performance. This microarray features data reproducibility with CV<4% and demonstrates high...
WOBURN, Mass., March 15, 2011 /PRNewswire/ -- Medical & Biological Laboratories Co., Ltd., MBL, has signed a non-exclusive license with Envoy Therapeutics for access to MBL's patented RIP-Chip technology. As part of the license agreement, MBL will receive upfront payment, annual licensing fees and potential milestone payments. Envoy Therapeutics will utilize the RIP-Chip technology for the company's drug discovery and development. MBL President Katsuhiko Nishida said, "We are pleased to...
Affymetrix, Inc. (NASDAQ: AFFX) today launched the Affymetrix® SNP 6 Core Reagent Kit, a comprehensive workflow solution that provides pre-mixed and validated reagents for nearly every step in the SNP 6.0 assay. This convenient kit eliminates the need for mixing tedious buffers, reduces the need to order from multiple vendors, and enables easier inventory management with a single kit expiration date. Santa Clara, CA (Vocus/PRWEB) March 14, 2011 Affymetrix, Inc. (NASDAQ: AFFX) today...
Biliary atresia (BA) is an inflammatory obliterative cholangiopathy with unknown etiology, leading to progressive fibrosis and cirrhosis. Microarray technology, emerged as an indispensable research tool for gene expression profiling, has been used to study the mechanism underlying BA, and allows the simultaneous analysis of thousands of transcripts within a single experiment. Some studies have been performed to investigate the gene expression profiling of livers from BA patients. However,...
IRVINE, California and AMSTERDAM, February 23, 2011 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that the company has received its fifth U.S. Food and Drug Administration (FDA) clearance for MammaPrint(R), its widely used breast cancer recurrence assay. The new clearance is comprised of two additional Agilent Microarray scanners and two Agilent Bioanalyzers, expanding laboratory capacity to handle the increasing number of MammaPrint,...
